DK0399321T3 - Gelfiltrering af varmebehandlet faktor VIII - Google Patents

Gelfiltrering af varmebehandlet faktor VIII

Info

Publication number
DK0399321T3
DK0399321T3 DK90108993.8T DK90108993T DK0399321T3 DK 0399321 T3 DK0399321 T3 DK 0399321T3 DK 90108993 T DK90108993 T DK 90108993T DK 0399321 T3 DK0399321 T3 DK 0399321T3
Authority
DK
Denmark
Prior art keywords
gel filtration
heat treated
factor viii
treated factor
peg precipitation
Prior art date
Application number
DK90108993.8T
Other languages
English (en)
Inventor
Christian Dr Goelker
Bernd Dr Bockskopf
William Brockway
Richard L Seng
Original Assignee
Miles Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Inc filed Critical Miles Inc
Application granted granted Critical
Publication of DK0399321T3 publication Critical patent/DK0399321T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Separation By Low-Temperature Treatments (AREA)
DK90108993.8T 1989-05-24 1990-05-12 Gelfiltrering af varmebehandlet faktor VIII DK0399321T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35631589A 1989-05-24 1989-05-24

Publications (1)

Publication Number Publication Date
DK0399321T3 true DK0399321T3 (da) 1993-08-09

Family

ID=23400965

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90108993.8T DK0399321T3 (da) 1989-05-24 1990-05-12 Gelfiltrering af varmebehandlet faktor VIII

Country Status (8)

Country Link
EP (1) EP0399321B1 (da)
JP (1) JP2931630B2 (da)
AT (1) ATE90875T1 (da)
AU (1) AU635535B2 (da)
CA (1) CA2017039C (da)
DE (1) DE69002033T2 (da)
DK (1) DK0399321T3 (da)
ES (1) ES2042138T3 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK162233C (da) * 1989-11-09 1992-03-16 Novo Nordisk As Fremgangsmaade til isolering af faktor viii fra blodplasma og pharmaceutisk praeparat indeholdende den saaledes isolerede fator viii
DE4434538C2 (de) * 1993-10-06 2000-08-10 Immuno Ag Verfahren zur Virusinaktivierung in Gegenwart eines Polyethers und eines chaotropen Agens
HRP940645A2 (en) * 1993-10-06 1996-12-31 Immuno Ag Process for virus deactivation in the presence of polyalkylene glycol and the pharmaceutical preparation thus obtained
US6632648B1 (en) 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
EP1820516B1 (en) 1999-02-22 2013-07-24 University of Connecticut Novel albumin-free factor VIII formulations
US6355243B1 (en) 1999-11-13 2002-03-12 Bayer Corporation Method of thrombolysis by local delivery of active plasmin
US7544500B2 (en) 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
US6964764B2 (en) 1999-11-13 2005-11-15 Talecris Biotherapeutics, Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
US6969515B2 (en) 1999-11-13 2005-11-29 Talecris Biotherapeutics, Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
UA103771C2 (ru) 2008-06-04 2013-11-25 Грифолз Терапьютикс Инк. Стрептокиназа, активирующая плазмин, способ и набор для получения плазмина
EP2385825B1 (en) 2008-11-07 2018-10-10 University of Connecticut Factor viii formulations
JP5789521B2 (ja) 2009-03-03 2015-10-07 グリフオルス・セラピユーテイクス・インコーポレーテツドＧｒｉｆｏｌｓ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． プラスミノーゲンを製造するための組成物、方法およびキット；ならびにそれから製造されるプラスミン
EP3642225A1 (en) 2017-06-23 2020-04-29 Baxalta Incorporated Purification of factor viii subspecies

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3631018A (en) * 1970-05-01 1971-12-28 Baxter Laboratories Inc Production of stable high-potency human ahf using polyethylene glycol and glycine to fractionate a cryoprecipitate of ahf concentrate
US4069216A (en) * 1975-06-16 1978-01-17 Edward Shanbrom, Inc. Simplified methods for preparation of very high purity Factor VIII concentrate
US4170639A (en) * 1978-07-10 1979-10-09 Warner-Lambert Company Antihemophilic factor concentrate and its production
FR2460305A2 (fr) * 1979-06-29 1981-01-23 Merieux Inst Procede de preparation d'un concentre de facteur viii
US4305871A (en) * 1980-09-02 1981-12-15 Edward Shanbrom Method of selectively increasing yield and purity of certain cryoprecipitate proteins by heating
US4650858A (en) * 1983-03-21 1987-03-17 Nordisk Gentofte A/S Concentrate of the antihemophilic factor VIII and a process for producing it
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
CA1293941C (en) * 1985-11-08 1992-01-07 Maria Erlinda Co-Sarno Method for preparing antihemophilic factor (ahf) by cold precipitation and for improving solubility of recovered ahf product
FR2651437A1 (fr) * 1989-09-05 1991-03-08 Lille Transfusion Sanguine Procede de preparation de concentre du complexe facteur viii-facteur von willebrand de la coagulation sanguine a partir de plasma total.
DK162233C (da) * 1989-11-09 1992-03-16 Novo Nordisk As Fremgangsmaade til isolering af faktor viii fra blodplasma og pharmaceutisk praeparat indeholdende den saaledes isolerede fator viii

Also Published As

Publication number Publication date
DE69002033D1 (de) 1993-07-29
EP0399321A2 (en) 1990-11-28
ATE90875T1 (de) 1993-07-15
EP0399321A3 (en) 1991-07-17
JP2931630B2 (ja) 1999-08-09
AU635535B2 (en) 1993-03-25
CA2017039C (en) 1999-08-03
AU5586890A (en) 1990-11-29
ES2042138T3 (es) 1993-12-01
JPH0347199A (ja) 1991-02-28
DE69002033T2 (de) 1993-09-30
EP0399321B1 (en) 1993-06-23
CA2017039A1 (en) 1990-11-24

Similar Documents

Publication Publication Date Title
ATE90875T1 (de) Gelfiltration von waermebehandeltem faktor viii.
GR3026751T3 (en) Process for producing collagen fibres
ATA123791A (de) Verfahren zur herstellung eines inaktivierten blutproduktes
DE69637181D1 (de) Vorrichtung zur inaktivierung von viralen kontaminationen in blutprodukten
ES2039943T3 (es) Procedimiento y aparato para la purificacion de agua empleando polipirrolidona.
DE69006940D1 (de) Verfahren zur Wärmebehandlung von Glasfaservorformen.
NO178716C (no) Fremgangsmåte for fremstilling av et stabilt konsentrat av Faktor VIII-von Willebrand faktor kompleks
DE69127694D1 (de) Herstellung und verwendung von transfer-faktor
EP0309787A3 (en) Process for producing a highly purified, virus-free and biologically active transferrin preparation
SE8104482L (sv) Forfarande for framstellning av ett faktor viii (ahf)-hogkoncentrat
ATE166881T1 (de) Verfahren zur herstellung von faktor viii
ATE196153T1 (de) Verfahren zur reinigung von faktor viii-von willebrand faktor (fviii:c-fvw) komplex aus menschlichem plasma
ATE112287T1 (de) Faktor viii- gelfiltration.
ATA118995A (de) Humanes virussicheres monomeres immunglobulin a und verfahren zu seiner herstellung
DE68909254D1 (de) Heparinbindende Gehirnmitogene.
DE68928634D1 (de) Verfahren zur Herstellung von aktivierten Killer-Monozyten und Verfahren zur Überprüfung ihrer tumoriziden Aktivität
FI903143A0 (fi) Menetelmä ihmisen nuhaviruksen serotyypittämiseksi
ATE81496T1 (de) Verfahren zur reinigung von dihydroxybiphenylen.
ATE90073T1 (de) Verfahren zur herstellung von n-acyl-anilinen.
IT8944004A0 (it) Procedimento per l'impianto di trattamento totale dei fumi provenienti da processi di combustione
IT1256237B (it) Procedimento per la preparazione di acyclovir
HUT51857A (en) Process for sterilization of bearers of pollensacks of plants